InvestorsHub Logo
Followers 144
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: Older/Poorer/Wiser post# 243253

Saturday, 01/25/2020 12:55:10 PM

Saturday, January 25, 2020 12:55:10 PM

Post# of 428756
O-

v1

Assumption:
- price: $1,600 / year / patient
- licensing revenue (Amarin): 25% ($400 / year / patient)
- cost of a "selling" company: $160 / year / patient … sales commission, marketing, etc.
- COGS: $360 / year / patient

1.) partnership:
Amarin: $400 / year / patient
"selling" company: $680 / year / patient (1,600 - 400 - 360 - 160)
2.) BO:
"selling" company: $1,080 / year / patient (1,600 - 360 - 160)

v2

Assumption:
- price: $2,000 / year / patient
- licensing revenue (Amarin): 25% ($500 / year / patient)
- cost of a "selling" company: $160 / year / patient … sales commission, marketing, etc.
- COGS: $360 / year / patient

1.) partnership:
Amarin: $500 / year / patient
"selling" company: $980 / year / patient (2,000 - 500 - 360 - 160)
2.) BO:
"selling" company: $1,480 / year / patient (2,000 - 360 - 160)

v3

Assumption:
- price: $1,200 / year / patient
- licensing revenue (Amarin): 25% ($300 / year / patient)
- cost of a "selling" company: $160 / year / patient … sales commission, marketing, etc.
- COGS: $360 / year / patient

1.) partnership:
Amarin: $300 / year / patient
"selling" company: $380 / year / patient (1,200 - 300 - 360 - 160)
2.) BO:
"selling" company: $680 / year / patient (1,200 - 360 - 160)

Best,
G


"There are some things money can't buy. … For these, there is AMRN."

Disclosure: I am long with this stock. I wrote this post myself, and it expresses my own opinions (IMHO). I am not receiving compensation for

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News